Rituximab in the Treatment of Patients With Bullous Pemphigoid

Clinical trial NCT00286325 · COMPLETED

Trial details

NCT number: NCT00286325
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Bullous Pemphigoid

Start date: 2005-03-01
Primary completion: 2010-03-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.